Twelve-Year Comparison of a Bjork–Shiley Mechanical Heart Valve with Porcine Bioprostheses
- 28 February 1991
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (9), 573-579
- https://doi.org/10.1056/nejm199102283240901
Abstract
Patients undergoing heartvalve replacement may receive a mechanical prosthesis, necessitating lifelong anticoagulant treatment, or a porcine bioprosthesis, which involves no absolute need for anticoagulants.Keywords
This publication has 18 references indexed in Scilit:
- Perspective on valvular heart disease: An updateJournal of the American College of Cardiology, 1989
- Acute failure of artificial heart valves.BMJ, 1988
- Is the dose of warfarin prescribed by American physicians unnecessarily high?Archives of Internal Medicine, 1987
- Pharmacology of heparin and warfarinJournal of the American College of Cardiology, 1986
- Therapeutic ranges in anticoagulant administration.BMJ, 1985
- Failure of Hancock Xenograft Valve: Importance of Valve Position (4- to 9-Year Follow-up)The Annals of Thoracic Surgery, 1983
- Comparison of late degenerative changes in porcine bioprostheses in the mitral and aortic valve position in the same patientThe American Journal of Cardiology, 1983
- The Ultimate Prognosis after Valve Replacement: An Assessment at Twenty YearsThe Annals of Thoracic Surgery, 1981
- A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.Heart, 1979
- Valve replacement—a perspectiveThe American Journal of Cardiology, 1975